Most common type of lung cancer, arising from secretory cells
Accounts for 84% of all lung cancers
Squamous cell carcinoma, large cell carcinoma, adenocarcinoma, and adenocarcinoma in situ
IMAGING
General Features
Nuclear Medicine Findings
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Microscopic Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
Surgery
Combined Chemoradiation
Systemic Therapy
Radiation Therapy
DIAGNOSTIC CHECKLIST
Image Interpretation Pearls
Selected References
Brodin NP et al: 18F-fluorodeoxyglucose PET in locally advanced non-small cell lung cancer: From predicting outcomes to guiding therapy. PET Clin. 15(1):55-63, 2020
Kim H et al: Clinical T category of non-small cell lung cancers: Prognostic performance of unidimensional versus bidimensional measurements at CT. Radiology. 290(3):807-13, 2019
Detterbeck FC: The eighth edition TNM stage classification for lung cancer: What does it mean on main street? J Thorac Cardiovasc Surg. 155(1):356-9, 2018
Kandathil A et al: Role of FDG PET/CT in the eighth edition of TNM staging of non-small cell lung cancer. Radiographics. 38(7):2134-49, 2018
Bhatkar D et al: Dual Tracer PET Imaging (68Ga-DOTATATE and 18F-FDG) Features in Pulmonary Carcinoid: Correlation with Tumor Proliferation Index. Indian J Nucl Med. 32(1):39-41, 2017
Greenspan BS: Role of PET/CT for precision medicine in lung cancer: perspective of the Society of Nuclear Medicine and Molecular Imaging. Transl Lung Cancer Res. 6(6):617-620, 2017
Related Anatomy
Loading...
Related Differential Diagnoses
Loading...
References
Tables
Tables
KEY FACTS
Imaging
Top Differential Diagnoses
Diagnostic Checklist
TERMINOLOGY
Definitions
Non-small cell lung cancer (NSCLC)
Most common type of lung cancer, arising from secretory cells
Accounts for 84% of all lung cancers
Squamous cell carcinoma, large cell carcinoma, adenocarcinoma, and adenocarcinoma in situ
IMAGING
General Features
Nuclear Medicine Findings
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Microscopic Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
Surgery
Combined Chemoradiation
Systemic Therapy
Radiation Therapy
DIAGNOSTIC CHECKLIST
Image Interpretation Pearls
Selected References
Brodin NP et al: 18F-fluorodeoxyglucose PET in locally advanced non-small cell lung cancer: From predicting outcomes to guiding therapy. PET Clin. 15(1):55-63, 2020
Kim H et al: Clinical T category of non-small cell lung cancers: Prognostic performance of unidimensional versus bidimensional measurements at CT. Radiology. 290(3):807-13, 2019
Detterbeck FC: The eighth edition TNM stage classification for lung cancer: What does it mean on main street? J Thorac Cardiovasc Surg. 155(1):356-9, 2018
Kandathil A et al: Role of FDG PET/CT in the eighth edition of TNM staging of non-small cell lung cancer. Radiographics. 38(7):2134-49, 2018
Bhatkar D et al: Dual Tracer PET Imaging (68Ga-DOTATATE and 18F-FDG) Features in Pulmonary Carcinoid: Correlation with Tumor Proliferation Index. Indian J Nucl Med. 32(1):39-41, 2017
Greenspan BS: Role of PET/CT for precision medicine in lung cancer: perspective of the Society of Nuclear Medicine and Molecular Imaging. Transl Lung Cancer Res. 6(6):617-620, 2017
STATdx includes over 200,000 searchable images, including x-ray, CT, MR, and ultrasound images. To access all images, please log in or subscribe.